Travel Time Thresholds, Vulnerability Index Provide Pharmacy Access Insights
Using a novel pharmacy vulnerability index, researchers identified US regions at the most risk of becoming pharmacy deserts.
Tirzepatide, Semaglutide Show Long-Term Benefits, But Are Not Cost-Effective
Tirzepatide and semaglutide show long-term health care cost savings but, the high cost of the medications offset the savings.
Weight, Diabetes Status Significantly Influence Perceptions of Food
Among various weights and diabetes diagnoses, researchers explored the differences in patients’ food perceptions when considering weight management and appetite.
Gilead Presents Data Demonstrating Established, Investigational HIV Drugs
Among the drugs presented, Biktarvy and lenacapavir, teropavimab, and zinlirvimab (LTZ) demonstrate rates of suppression of HIV, and vesatolimod is well tolerated.
Pharmacists Can Act as Navigators for Patients Using Digital Health Tools
George Van Antwerp, MBA, senior vice president of Product Innovation and Strategic Planning at Prime Therapeutics, discusses how pharmacists can help patients decide which digital tools are best for them.
Over 300 Pharmacy Closures Reported in the Last 3 Months
A new report from the American Economic Liberties Project presents the continued challenges pharmacies face since Congress’ failure to pass PBM reform at the end of 2024.
Common Trends in GLP-1 Use Amid Increased Indications
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, discussed the common trends in GLP-1 use she’s seen amongst her patients as well as her extensive experience working with this medication class.
Automated Insulin Delivery Could Be Used for Older Adults With Type 1 Diabetes
These findings challenge the common assumption that older adults might struggle to use more advance medical devices.
Conference Preview: APhA 2025 Annual Meeting and Exposition
This year’s meeting will take place from March 21 to 24 in Nashville, Tennessee.
Zero Cases of HIV Acquisition Seen for Apretude, Cabenuva Treatment
Additional data shows that an investigational drug, given every 4 months with Apretude, kept viral levels suppressed for patients who were already on stable treatment.
Drug Regimen For HIV Shows Non-Inferiority to Antiretroviral Therapies
These findings are shared as late-breaking data at the 32nd Conference on Retroviruses and Opportunistic Infections (CROI) being held in San Francisco, California.
Healthier Diet, Lower WHR Improved Cognitive Brain Function
Researchers compared changes in diet quality and waist-to-hip ratio during midlife with that of hippocampal connectivity and cognitive function in later life.
Drug Shortages, Affordability Remain Top Concerns in Managed Care Pharmacy
Approximately, 62% of respondents stated that the number of active drug shortages could potentially increase by more than 25% within the next 5 years.
What Does the Future of Pain Medicine Look Like?
With minimal pharmacological treatments coming to market for chronic pain, researchers have explored new technologies for advancing pain treatment across the globe.
Bipartisan Bill Aims to Combat PBMs’ Medicaid Spread-Pricing
US Senators on both sides of the aisle came together to announce the Protecting Pharmacies in Medicaid Act.
New Data Shows Cebranopadol’s Potential in Acute Pain Management
A conversation with Todd Bertoch, MD, chief medical officer for pain research at CenExel and an investigator on the ALLEVIATE-2 trial.
Oral Antiviral Demonstrates Prevention of COVID-19 in Phase 3 Study
Ensitrelvir demonstrated a 67% relative risk reduction of developing symptomatic COVID-19 in household contact patients.
Deucravacitinib Shows Improvement in Symptoms of Psoriatic Arthritis
Deucravacitinib (Sotyktu) also demonstrates improvements in signs and symptoms, extra-articular manifestations, and patient-reported outcomes.
Baricitinib Shows Significant Hair Regrowth for Pediatric Patients With Alopecia Areata
Patients aged 12 to under 18 saw clinically meaningful regrowth on the scalp, eyebrow, and eyelashes with both high-dose and low-dose treatment.
Q&A: Who is Responsible for Addressing the Growing Issue of Pharmacy Deserts?
Representatives from Cencora’s Good Neighbor Pharmacy Network discussed legislation created to improve declining pharmacy rates and who is accountable for addressing pharmacy deserts.
CagriSema Demonstrates Significant Weight Loss at 68 Weeks
Approximately 89.7% of patients taking CagriSema achieve the coprimary end point of weight loss of 5% or more compared with 30.3% on the placebo.
Bleeding Disorders Significantly Impact Quality of Life Among Women
Researchers analyzed historical characteristics of bleeding disorders among women by highlighting clinical challenges and management strategies.
Tapinarof Results in Mild Atopic Dermatitis Activity During Treatment-Free Period
Investigators note that low itch and mild disease severity are maintained following a treatment-free interval of 80 days.
Younger Recommended Screening Age Can Lessen Colorectal Cancer Burden
Researchers investigated the health benefits, utilization, harms, and costs associated with the use of alternative methods for colorectal cancer screening in Australia.
Q&A: Challenges Health Systems May Face When Integrating Biosimilars
A conversation with Chelsee Jensen, PharmD, BCPS, director of formulary management at the Mayo Clinic.
COVID-19 mRNA Vaccines May Reduce Long COVID Risk in Children, Adolescents
COVID-19 vaccination before a SARS-CoV-2 infection was associated with a 75% reduced likelihood of long COVID symptoms that impact daily functioning among patients between the ages of 5 and 17 years.
Nonlinear Relationship Found Between Lipoprotein Cholesterol Ratio, Risk of Diabetic Kidney Disease
Non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol levels could potentially be a valuable biomarker for determining the risk of diabetic kidney disease.
State Immunization Policies for Pharmacists Hinder US Vaccine Uptake
IQVIA released a report detailing pharmacists’ authority to administer vaccines in the US as well as adults’ overall vaccination rates by state.
Semaglutide Associated With Modest Increased Risk of Nonarteritic Anterior Ischemic Optic Neuropathy
In a previous study, results showed that patients taking semaglutide could be at a higher risk of nonarteritic anterior ischemic optic neuropathy (NAION), causing blindness.
How Pharmacy Deserts are Being Defined, Identified
Jennifer Zilka and Kyle Pudenz, DBA, introduced the issue of pharmacy deserts and discussed what has been driving store closures across the US.